Cathlab Forum | tctmd.com
Hub page
Hub page
A SCAI survey found high rates of spinal injury amid signs that careers could be longer with better prevention and management.
Patients can now easily buy these tests, but cardiologists must consider their quality when using the information to guide care.
Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.
The US data also point to lower costs and shorter stays at these expert centers, an argument for regionalized care akin to STEMI.
More research is needed to see how this factor could inform risk tools and whether addressing it reduces future disease.
Though arterial thrombotic risk was higher with hormonal contraception use, the absolute excess risks were low.
Early data in mice and human tissue indicate that using drugs or gene therapy could allow for cardiac healing in ischemic HF.
The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical issues.
The DCB looks good in select cases, but given its high price tag, exactly when to use it is still up for discussion, say experts.
A one-stop approach resulted in a new diagnosis of HF for 3% of the clinic’s visitors, who then were referred for timely treatment.